Pfizer Covid Vaccine for Younger Kids Wins FDA Panel's Backing

The Food and Drug Administration's vaccines advisory committee voted 17-0, with one abstention, to back the immunization, which is intended for children from 5 to 11 years old and is one-third the dose currently given to people age 12 and older.

from Google Alert - Business https://ift.tt/3nwpNR9
The Food and Drug Administration's vaccines advisory committee voted 17-0, with one abstention, to back the immunization, which is intended for children from 5 to 11 years old and is one-third the dose currently given to people age 12 and older. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize